BMRN Financial Facts

Equity in the loss of BioMarin/Genzyme LLC: -204K
Interest income: 1.02M
See Full Income Statement

Total current liabilities: 347.7M
Other current assets: 77.56M
See Full Balance Sheet

BioMarin Pharmaceutical Inc. (BMRN) Earnings

  |   Expand Research on BMRN
Next EPS Date 10/23/15 *Est. EPS Growth Rate -121.7% *Last Qtr.
Average EPS % Beat Rate +23.8% Revenue Growth Rate +30.3% *Last Qtr.
Average % Move 1-Wk after EPS +2.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/21/13 Q412 -$0.43-$0.27 -$0.16$130.96M$129.7M = Details
2/16/12 Q411 -$0.23-$0.11 -$0.12$107.9M$115.3M = Details
10/24/13 Q313 -$0.38-$0.30 -$0.08$136.9M$140M = Details
4/26/12 Q112 -$0.21-$0.14 -$0.07$116.6M$119.24M = Details
8/1/12 Q212 -$0.27-$0.21 -$0.06$124M$121.54M = Details
4/25/13 Q113 -$0.31-$0.29 -$0.02N/A$131.44M = Details
8/3/15 Q215 -$0.51-$0.53 +$0.02$250M$218.16M = Details
7/28/11 Q211 -$0.05-$0.11 +$0.06$110.63M$105.9M Details